FR2512672A1 - Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant - Google Patents

Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant Download PDF

Info

Publication number
FR2512672A1
FR2512672A1 FR8117492A FR8117492A FR2512672A1 FR 2512672 A1 FR2512672 A1 FR 2512672A1 FR 8117492 A FR8117492 A FR 8117492A FR 8117492 A FR8117492 A FR 8117492A FR 2512672 A1 FR2512672 A1 FR 2512672A1
Authority
FR
France
Prior art keywords
sep
htp
5htp
purine
hydroxytryptophan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8117492A
Other languages
English (en)
French (fr)
Other versions
FR2512672B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Claude Laruelle
Marcel Lepant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panmedica SA
Original Assignee
Panmedica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panmedica SA filed Critical Panmedica SA
Priority to FR8117492A priority Critical patent/FR2512672A1/fr
Priority to FR8213980A priority patent/FR2531713A2/fr
Priority to ES515709A priority patent/ES515709A0/es
Priority to JP57160728A priority patent/JPS58109417A/ja
Priority to GR69287A priority patent/GR77003B/el
Priority to CA000411517A priority patent/CA1219582A/en
Priority to ZA826752A priority patent/ZA826752B/xx
Priority to AU88474/82A priority patent/AU557715B2/en
Priority to US06/418,599 priority patent/US4472387A/en
Priority to EP82401683A priority patent/EP0074909B1/fr
Priority to DE198282401683T priority patent/DE74909T1/de
Priority to AT82401683T priority patent/ATE13975T1/de
Priority to DE8282401683T priority patent/DE3264433D1/de
Publication of FR2512672A1 publication Critical patent/FR2512672A1/fr
Application granted granted Critical
Publication of FR2512672B1 publication Critical patent/FR2512672B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
FR8117492A 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant Granted FR2512672A1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR8117492A FR2512672A1 (fr) 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
FR8213980A FR2531713A2 (fr) 1981-09-16 1982-08-11 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
JP57160728A JPS58109417A (ja) 1981-09-16 1982-09-14 セロトニンの代謝欠之を補正するための新規な薬剤
ES515709A ES515709A0 (es) 1981-09-16 1982-09-14 "procedimiento de preparacion de un complejo inosina-(l) 5-htp".
CA000411517A CA1219582A (en) 1981-09-16 1982-09-15 Pharmaceutical compositions capable of increasing cerebral serotonin concentration
ZA826752A ZA826752B (en) 1981-09-16 1982-09-15 Pharmaceutical compositions capable of increasing cerebral serotonin concentration
GR69287A GR77003B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-09-16 1982-09-15
AU88474/82A AU557715B2 (en) 1981-09-16 1982-09-16 5-hydroxytryptophane and derivatives with nitrogenous heterocyclic compounds
US06/418,599 US4472387A (en) 1981-09-16 1982-09-16 Pharmaceutical compositions capable of increasing cerebral serotonin concentration
EP82401683A EP0074909B1 (fr) 1981-09-16 1982-09-16 Nouvelles compositions à base de 5-hydroxytryptophane, leur procédé de préparation et médicaments les contenant
DE198282401683T DE74909T1 (de) 1981-09-16 1982-09-16 Zusammensetzungen mit gehalt an 5-hydroxytryptophan, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
AT82401683T ATE13975T1 (de) 1981-09-16 1982-09-16 Zusammensetzungen mit gehalt an 5hydroxytryptophan, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE8282401683T DE3264433D1 (en) 1981-09-16 1982-09-16 Compositions on the basis of 5-hydroxy-tryptophane, manufacturing process and medicaments containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8117492A FR2512672A1 (fr) 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant

Publications (2)

Publication Number Publication Date
FR2512672A1 true FR2512672A1 (fr) 1983-03-18
FR2512672B1 FR2512672B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-02-24

Family

ID=9262193

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8117492A Granted FR2512672A1 (fr) 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant

Country Status (3)

Country Link
JP (1) JPS58109417A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2512672A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA826752B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2928386B2 (ja) * 1992-07-08 1999-08-03 協和醗酵工業株式会社 うつ病治療剤

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081539A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1970-02-25 1971-12-03 Made Labor Sa
GB1535778A (en) * 1976-12-06 1978-12-13 Mac Sweeney D Compounds useful in treatment of unipolar depression
DE2841170A1 (de) * 1978-09-21 1980-04-03 Pharmazeutische Praeparate Apo Hypnotikum

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1601066A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1966-06-18 1970-08-10

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081539A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1970-02-25 1971-12-03 Made Labor Sa
GB1535778A (en) * 1976-12-06 1978-12-13 Mac Sweeney D Compounds useful in treatment of unipolar depression
DE2841170A1 (de) * 1978-09-21 1980-04-03 Pharmazeutische Praeparate Apo Hypnotikum

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/78 *

Also Published As

Publication number Publication date
ZA826752B (en) 1983-07-27
FR2512672B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-02-24
JPS58109417A (ja) 1983-06-29
JPS6254403B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-11-14

Similar Documents

Publication Publication Date Title
EP0154756B1 (fr) Citrate de vinpocetine et son procédé de préparation
CH639653A5 (fr) Aminothiazoles et composition pharmaceutique les contenant.
FR2663934A1 (fr) Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
EP0074909B1 (fr) Nouvelles compositions à base de 5-hydroxytryptophane, leur procédé de préparation et médicaments les contenant
FR2553777A1 (fr) Nouveaux complexes de platine et leur application en therapeutique
EP0092458A2 (fr) Dérives d'imidazo(1,2-a)pyridine, leur préparation et leur application en thérapeutique
WO2021176093A1 (fr) Dérivés de nicotinamide mononucléotide et de bis-nicotinamide dinucléotide pour le traitement de l'arythmie
EP0846688B1 (fr) Nouveaux dérivés de l'imidazoline ayant une affinité pour les récepteurs aux imidazolines
US4511557A (en) Pharmaceutical composition
EP0452204B1 (fr) Nouveaux dérivés du 3-aminochromane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2512672A1 (fr) Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
EP0099799B1 (fr) Nouveaux sels d'amino- (et imino-) acides alpha, omega-sulfoniques N-substitués, vecteurs cationiques de haute pénétration cellulaire, procédé d'obtention
US20230100692A1 (en) Synthetic process and novel intermediates
WO1991002725A1 (fr) Derives de la 5-amino-1,2,3,4-tetrahydro-acridine et applications comme medicaments
BE898324A (fr) Derives benzylideniques soufres, leur preparation et leur application en therapeutique.
EP0575481B1 (fr) Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4
CH624922A5 (en) Process for the preparation of new methylamine derivatives
US4719313A (en) Gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes
FR2472935A1 (fr) Compositions pharmaceutiques ayant un effet immunodepresseur a base de derives de l'isothiouree
FR2893616A1 (fr) Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
EP0098204A1 (fr) Compositions thérapeutiques à base d'hydrazones N-substituées et nouvelles hydrazones N-substituées
CH625249A5 (en) Process for the preparation of imidazothiazole derivatives
BE897069A (fr) Derives de la cystamine, leur preparation et les compositions comme facteur de croissance qui les contiennent
EP0017525B1 (fr) Nouveaux dérivés tétrahydroalstoniques, leur préparation et leur application en tant que médicaments
FR2494693A1 (fr) Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
EM Correction of a material error concerning inscription in the national patent register
ST Notification of lapse